Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion type Assertion NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_head.
- NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion description "[Although no relation between plasma IGF-I levels and IGF-I genotypes was found, women who carried the genotypes containing the (CA)17 or (CA)19 allele were associated with a significantly decreased (OR = 0.80, 95% CI: 0.64-1.00) or increased (OR = 1.23, 95% CI: 1.04-1.47) risk of breast cancer, respectively, and women who carried the genotypes containing any of the 4 rare alleles, (CA)11, (CA)13, (CA)16 and (CA)23, were associated with a nonsignificantly increased risk of breast cancer (OR = 1.92, 95% CI: 0.92-4.02) compared to those who did not carry the specific alleles.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_provenance.
- NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion evidence source_evidence_literature NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_provenance.
- NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion SIO_000772 15386404 NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_provenance.
- NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion wasDerivedFrom befree-20150227 NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_provenance.
- NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_assertion wasGeneratedBy ECO_0000203 NP276854.RA73UZAmLm7aSP14r_9nq78diJR-D5SmqR_g7VXyvBM00130_provenance.